Squarepoint Ops LLC Catalyst Pharmaceuticals, Inc. Transaction History

Squarepoint Ops LLC

$99.2 Billion
Q4 2024

A detailed history of Squarepoint Ops LLC transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 111,705 shares of CPRX stock, worth $2.42 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

111,705

Previous 80,863 38.14%

Holding current value

$2.42 Million

Previous $1.61 Million 45.05%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$19.73 - $23.93 $608,512 - $738,049	30,842 Added 38.14%	111,705 $2.33 Million
Q3 2024 Nov 14, 2024	BUY	$15.19 - $21.35 $950,757 - $1.34 Million	62,591 Added 342.55%	80,863 $1.61 Million
Q2 2024 Aug 14, 2024	SELL	$14.68 - $16.92 $2.5 Million - $2.88 Million	-170,088 Reduced 90.3%	18,272 $283,000
Q1 2024 May 15, 2024	BUY	$13.18 - $17.11 $2.48 Million - $3.22 Million	188,360 New	188,360 $3 Million
Q1 2023 May 15, 2023	BUY	$14.34 - $21.05 $954,843 - $1.4 Million	66,586 New	66,586 $1.1 Million
Q1 2022 May 16, 2022	SELL	$5.31 - $8.31 $474,374 - $742,382	-89,336 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$5.21 - $7.45 $465,440 - $665,553	89,336 New	89,336 $605,000
Q2 2021 Aug 16, 2021	SELL	$4.29 - $6.05 $325,100 - $458,475	-75,781 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$3.45 - $4.69 $91,683 - $124,636	-26,575 Reduced 25.96%	75,781 $349,000
Q4 2020 Feb 16, 2021	BUY	$2.97 - $3.83 $113,154 - $145,919	38,099 Added 59.29%	102,356 $342,000
Q3 2020 Nov 16, 2020	BUY	$2.97 - $5.08 $190,843 - $326,425	64,257 New	64,257 $191,000
Q2 2020 Aug 14, 2020	SELL	$3.48 - $5.05 $860,235 - $1.25 Million	-247,194 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$2.61 - $5.21 $1.98 Million - $3.94 Million	-756,848 Reduced 75.38%	247,194 $952,000
Q4 2019 Feb 14, 2020	BUY	$3.67 - $5.7 $3.63 Million - $5.64 Million	989,519 Added 6813.46%	1,004,042 $3.77 Million
Q3 2019 Nov 14, 2019	SELL	$3.89 - $7.43 $101,050 - $193,009	-25,977 Reduced 64.14%	14,523 $77,000
Q2 2019 Aug 14, 2019	BUY	$2.7 - $6.11 $109,350 - $247,455	40,500 New	40,500 $156,000
Q1 2019 May 15, 2019	SELL	$2.11 - $5.33 $95,260 - $240,633	-45,147 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$1.92 - $3.62 $86,682 - $163,432	45,147 New	45,147 $87,000
Q3 2018 Nov 14, 2018	SELL	$2.81 - $3.78 $566,074 - $761,481	-201,450 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$2.26 - $3.84 $164,866 - $280,128	72,950 Added 56.77%	201,450 $629,000
Q1 2018 May 15, 2018	SELL	$2.39 - $4.01 $138,961 - $233,153	-58,143 Reduced 31.15%	128,500 $307,000
Q4 2017 Feb 14, 2018	BUY	$2.51 - $4.4 $275,454 - $482,869	109,743 Added 142.71%	186,643 $730,000
Q3 2017 Nov 14, 2017	BUY	$2.4 - $2.94 $184,560 - $226,086	76,900	76,900 $194,000

Others Institutions Holding CPRX

# of Institutions

346

Shares Held

98.4M

Call Options Held

13.4K

Put Options Held

11.7K

View Full List

About CATALYST PHARMACEUTICALS, INC.

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.23B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

More about CPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account

Squarepoint Ops LLC Catalyst Pharmaceuticals, Inc. Transaction History